Immune cells may hold key to predicting kidney disease relapse

This study looks at immune cell patterns in people with three types of nephrotic syndrome—membranous nephropathy, minimal change disease, and focal segmental glomerulosclerosis. Researchers aim to see if certain immune cells can serve as biomarkers to track how well a patient responds to treatment or to predict when the disease might come back. Participants receive standard therapies (rituximab or corticosteroids) and are followed for remission, relapse, and other health events.